keyword
https://read.qxmd.com/read/38629469/iron-efflux-by-ieta-enhances-%C3%AE-lactam-aztreonam-resistance-and-is-linked-to-oxidative-stress-through-cellular-respiration-in-riemerella-anatipestifer
#21
JOURNAL ARTICLE
Mafeng Liu, Mengying Wang, Mi Huang, Qun Gao, Dekang Zhu, Mingshu Wang, Renyong Jia, Shun Chen, Xinxin Zhao, Qiao Yang, Ying Wu, Shaqiu Zhang, Juan Huang, Xumin Ou, Sai Mao, Bin Tian, Di Sun, Anchun Cheng
BACKGROUND: Riemerella anatipestifer encodes an iron acquisition system, but whether it encodes the iron efflux pump and its role in antibiotic resistance are largely unknown. OBJECTIVES: To screen and identify an iron efflux gene in R. anatipestifer and determine whether and how the iron efflux gene is involved in antibiotic resistance. METHODS: In this study, gene knockout, streptonigrin susceptibility assay and inductively coupled plasma mass spectrometry were used to screen for the iron efflux gene ietA...
April 17, 2024: Journal of Antimicrobial Chemotherapy
https://read.qxmd.com/read/38628673/anemia-in-patients-receiving-anticancer-treatments-focus-on-novel-therapeutic-approaches
#22
REVIEW
Claudia Bozzini, Fabiana Busti, Giacomo Marchi, Alice Vianello, Claudio Cerchione, Giovanni Martinelli, Domenico Girelli
Anemia is common in cancer patients and impacts on quality of life and prognosis. It is typically multifactorial, often involving different pathophysiological mechanisms, making treatment a difficult task. In patients undergoing active anticancer treatments like chemotherapy, decreased red blood cell (RBC) production due to myelosuppression generally predominates, but absolute or functional iron deficiency frequently coexists. Current treatments for chemotherapy-related anemia include blood transfusions, erythropoiesis-stimulating agents, and iron supplementation...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38628339/intravenous-iron-therapy-for-patients-with-iron-deficiency-and-heart-failure-a-systematic-review-and-meta-analysis-of-randomized-controlled-trials
#23
JOURNAL ARTICLE
Mohammed Mhanna, Michael C Sauer, Ahmad Al-Abdouh, Ahmad Jabri, Azizullah Beran, Mahmoud Barbarawi, Shareef Mansour, Elias B Hanna
INTRODUCTION: Heart failure (HF) presents a significant health challenge, with intravenous (IV) iron therapy considered a potential treatment avenue. METHOD: We assessed IV iron therapy's efficacy in HF patients with concurrent iron deficiency versus standard of care. Primary outcomes included the composite of HF hospitalizations or cardiovascular-related mortality, HF hospitalizations, and all-cause, HF, and cardiovascular mortality rates. Secondary measures encompassed improvements in New York Heart Association functional classification, quality of life, 6-minute walk test, left ventricular ejection fraction, and adverse events...
2024: Proceedings of the Baylor University Medical Center
https://read.qxmd.com/read/38628330/iron-therapy-for-patients-with-iron-deficiency-and-heart-failure-a-treatment-strategy-that-is-increasingly-opaque
#24
JOURNAL ARTICLE
Jincy Thankachen, Shelley Hall, Amit Alam
No abstract text is available yet for this article.
2024: Proceedings of the Baylor University Medical Center
https://read.qxmd.com/read/38627553/unlocking-ferroptosis-in-prostate-cancer-the-road-to-novel-therapies-and-imaging-markers
#25
REVIEW
Pham Hong Anh Cao, Abishai Dominic, Fabiola Ester Lujan, Sanjanaa Senthilkumar, Pratip K Bhattacharya, Daniel E Frigo, Elavarasan Subramani
Ferroptosis is a distinct form of regulated cell death that is predominantly driven by the build-up of intracellular iron and lipid peroxides. Ferroptosis suppression is widely accepted to contribute to the pathogenesis of several tumours including prostate cancer. Results from some studies reported that prostate cancer cells can be highly susceptible to ferroptosis inducers, providing potential for an interesting new avenue of therapeutic intervention for advanced prostate cancer. In this Perspective, we describe novel molecular underpinnings and metabolic drivers of ferroptosis, analyse the functions and mechanisms of ferroptosis in tumours, and highlight prostate cancer-specific susceptibilities to ferroptosis by connecting ferroptosis pathways to the distinctive metabolic reprogramming of prostate cancer cells...
April 16, 2024: Nature Reviews. Urology
https://read.qxmd.com/read/38626916/superparamagnetic-iron-oxide-nanoparticles-reprogram-the-tumor-microenvironment-and-reduce-lung-cancer-regrowth-after-crizotinib-treatment
#26
JOURNAL ARTICLE
Natalie K Horvat, Sara Chocarro, Oriana Marques, Tobias A Bauer, Ruiyue Qiu, Alberto Diaz-Jimenez, Barbara Helm, Yuanyuan Chen, Stefan Sawall, Richard Sparla, Lu Su, Ursula Klingmüller, Matthias Barz, Matthias W Hentze, Rocío Sotillo, Martina U Muckenthaler
ALK-positive NSCLC patients demonstrate initial responses to ALK tyrosine kinase inhibitor (TKI) treatments, but eventually develop resistance, causing rapid tumor relapse and poor survival rates. Growing evidence suggests that the combination of drug and immune therapies greatly improves patient survival; however, due to the low immunogenicity of the tumors, ALK-positive patients do not respond to currently available immunotherapies. Tumor-associated macrophages (TAMs) play a crucial role in facilitating lung cancer growth by suppressing tumoricidal immune activation and absorbing chemotherapeutics...
April 16, 2024: ACS Nano
https://read.qxmd.com/read/38626848/the-crosstalk-between-oncogenic-signaling-and-ferroptosis-in-cancer
#27
REVIEW
Qianghu Pang, Zhirou Tang, Lianxiang Luo
Ferroptosis, a novel form of cell death regulation, was identified in 2012. It is characterized by unique features that differentiate it from other types of cell death, including necrosis, apoptosis, autophagy, and pyroptosis. Ferroptosis is defined by an abundance of iron ions and lipid peroxidation, resulting in alterations in subcellular structures, an elevation in reactive oxygen species (ROS), a reduction in glutathione (GSH) levels, and an augmentation in Fe (II) cytokines. Ferroptosis, a regulated process, is controlled by an intricate network of signaling pathways, where multiple stimuli can either enhance or hinder the process...
April 16, 2024: Critical Reviews in Oncology/hematology
https://read.qxmd.com/read/38626642/photodynamic-anticancer-activity-evaluation-of-novel-5-aminolevulinic-acid-and-3-hydroxypyridinone-conjugates
#28
JOURNAL ARTICLE
Jingqi Zhang, Shengli Yuan, Miaoliang Fan, Keren Wang, Jianan Guo, Anjie Zang, Jinhui Ren, Weike Su, Changjun Zhang, Yuanyuan Xie
5-Aminolevulinic acid (ALA) and its derivatives, serving as the endogenous precursor of the photosensitizer (PS) protoporphyrin IX (PpIX), successfully applied in tumor imaging and photodynamic therapy (PDT). ALA and its derivatives have been used to treat actinic keratosis (AK), basal cell carcinoma (BCC), and improve the detection of superficial bladder cancer. However, the high hydrophilicity of ALA and the conversion of PpIX to heme have limited the accumulation of PpIX, hindering the efficiency and potential application of ALA-PDT...
April 15, 2024: Bioorganic & Medicinal Chemistry
https://read.qxmd.com/read/38625730/clinical-efficacy-and-safety-of-intravenous-ferric-carboxymaltose-for-treatment-of-restless-legs-syndrome-a-multicenter-randomized-placebo-controlled-clinical-trial
#29
JOURNAL ARTICLE
Christopher J Earley, Diego García-Borreguero, Mark Falone, John W Winkelman
STUDY OBJECTIVES: Iron therapy is associated with improvements in restless legs syndrome (RLS). This multicenter, randomized, double-blind study evaluated the effect of intravenous ferric carboxymaltose (FCM) on RLS. METHODS: A total of 209 adult patients with a baseline International Restless Legs Syndrome (IRLS) score ≥15 were randomized (1:1) to FCM (750 mg/15 mL) or placebo on study Days 0 and 5. Ongoing RLS medication was tapered starting on Day 5, with the goal of discontinuing treatment or achieving the lowest effective dose...
April 16, 2024: Sleep
https://read.qxmd.com/read/38622725/human-mesenchymal-stem-cells-derived-exosomes-improve-ovarian-function-in-chemotherapy-induced-premature-ovarian-insufficiency-mice-by-inhibiting-ferroptosis-through-nrf2-gpx4-pathway
#30
JOURNAL ARTICLE
Yuan Zhou, Jinfa Huang, Lingling Zeng, Qian Yang, Fangjuan Bai, Qiqing Mai, Kaixian Deng
BACKGROUND: Chemotherapy exposure has become a main cause of premature ovarian insufficiency (POI). This study aimed to evaluate the role and molecular mechanism of human umbilical cord mesenchymal stem cell-derived exosomes (hUMSC-Exos) in ovarian function protection after chemotherapy. METHODS: hUMSC-Exos were applied to cyclophosphamide-induced premature ovarian insufficiency mice and human ovarian granulosa tumor cells (KGN) to determine their effects on follicular development and granulosa cell apoptosis...
April 15, 2024: Journal of Ovarian Research
https://read.qxmd.com/read/38621329/cartilage-protective-and-anti-edema-effects-of-jtf-in-osteoarthritis-via-inhibiting-ncoa4-hmgb1-driven-ferroptosis-and-aquaporin-dysregulation
#31
JOURNAL ARTICLE
Yudong Liu, Tengteng Xu, Zhaochen Ma, Chu Zhang, Mingzhu Xu, Qun Li, Weiheng Chen, Yanqiong Zhang, Chunfang Liu, Na Lin
BACKGROUND: Preventing joint edema is crucial in halting osteoarthritis (OA) progression. Growing clinical evidence indicate that Jianpi-Tongluo Formula (JTF) may have a promising anti-edema effect. However, the therapeutic properties of JTF and the underlying mechanisms remains unclear. MATERIALS AND METHODS: An OA rat model was established and employed to evaluate pharmacological effects of JTF in vivo based on dynamic histopathologic assessments and micro-CT observations...
April 6, 2024: Phytomedicine
https://read.qxmd.com/read/38618666/oral-iron-supplementation-new-formulations-old-questions
#32
JOURNAL ARTICLE
Kostas Pantopoulos
Iron deficiency anemia and pre-anemic iron deficiency are the most frequent pathologies. The first line of treatment involves oral iron supplementation. The simplest, least expensive, and most frequently prescribed drug is ferrous sulfate, while other ferrous salts and ferric complexes with polysaccharides or succinylated milk proteins are also widely used. In recent years, novel iron formulations have been developed, such as the lipophilic iron donor ferric maltol, or nanoparticle encapsulated sucrosomial® iron...
April 11, 2024: Haematologica
https://read.qxmd.com/read/38618303/concurrent-challenges-in-idiopathic-hypereosinophilic-syndrome-complicating-beta-thalassemia-major-a-case-report
#33
Varun Daiya, Sunil Kumar, Sourya Acharya, Utkarsh Pradeep, Sharwari Jaiswal
This case report highlights the uncommon idiopathic hypereosinophilic syndrome (HES) complicating beta-thalassemia major, presenting a diagnostic and management challenge. Beta-thalassemia major, characterized by impaired beta-globin synthesis, necessitates regular blood transfusions and iron chelation therapy. HES, a rare disorder marked by persistent eosinophilia, adds complexity to the clinical course. We present the case of a 27-year-old male with beta-thalassemia major who developed fever, weakness, and weight loss and was subsequently diagnosed with HES...
March 2024: Curēus
https://read.qxmd.com/read/38618243/enhancing-metformin-induced-tumor-metabolism-destruction-by-glucose-oxidase-for-triple-combination-therapy
#34
JOURNAL ARTICLE
Rangrang Fan, Linrui Cai, Hao Liu, Hongxu Chen, Caili Chen, Gang Guo, Jianguo Xu
Despite decades of laboratory and clinical trials, breast cancer remains the main cause of cancer-related disease burden in women. Considering the metabolism destruction effect of metformin (Met) and cancer cell starvation induced by glucose oxidase (GOx), after their efficient delivery to tumor sites, GOx and Met may consume a large amount of glucose and produce sufficient hydrogen peroxide in situ . Herein, a pH-responsive epigallocatechin gallate (EGCG)-conjugated low-molecular-weight chitosan (LC-EGCG, LE) nanoparticle (Met-GOx/Fe@LE NPs) was constructed...
March 2024: Journal of Pharmaceutical Analysis
https://read.qxmd.com/read/38616529/daprodustat-a-hypoxia-inducible-factor-prolyl-hydroxylase-inhibitor-for-anemia-of-chronic-kidney-disease
#35
REVIEW
Haley N Johnson, Lalita Prasad-Reddy
OBJECTIVE: The objective was to review the safety and efficacy of daprodustat, a hypoxia-inducible factor-prolyl hydroxylase inhibitor (HIF-PHI) in the treatment of anemia of chronic kidney disease (CKD). DATA SOURCES: A literature search was conducted in MEDLINE, EMBASE, and ClinicalTrials.gov using the keywords "daprodustat," "GSK1278863," and "hypoxia-inducible factor-prolyl hydroxylase inhibitors" from January 2010 through November 2023. STUDY SELECTION AND DATA EXTRACTION: Literature was included if it evaluated pharmacology, pharmacokinetics, efficacy, and/or safety of daprodustat in human subjects and was reported in English...
April 14, 2024: Annals of Pharmacotherapy
https://read.qxmd.com/read/38615895/mechanistic-insights-and-emerging-therapeutic-stratagems-for-alzheimer-s-disease
#36
REVIEW
Kayalvizhi Rajendran, Uma Maheswari Krishnan
Alzheimer's disease (AD), a multi-factorial neurodegenerative disorder has affected over 30 million individuals globally and these numbers are expected to increase in the coming decades. Current therapeutic interventions are largely ineffective as they focus on a single target. Development of an effective drug therapy requires a deep understanding of the various factors influencing the onset and progression of the disease. Aging and genetic factors exert a major influence on the development of AD. Other factors like post-viral infections, iron overload, gut dysbiosis, and vascular dysfunction also exacerbate the onset and progression of AD...
April 12, 2024: Ageing Research Reviews
https://read.qxmd.com/read/38615871/the-new-era-of-lung-cancer-therapy-combining-immunotherapy-with-ferroptosis
#37
REVIEW
Yawen Li, Halahati Tuerxun, Yixin Zhao, Xingyu Liu, Xi Li, Shuhui Wen, Yuguang Zhao
Ferroptosis is an unconventional programmed cell death mode caused by phospholipid peroxidation dependent on iron. Emerging immunotherapies (especially immune checkpoint inhibitors) have the potential to enhance lung cancer patients' long-term survival. Although immunotherapy has yielded significant positive applications in some patients, there are still many mechanisms that can cause lung cancer cells to evade immunity, thus leading to the failure of targeted therapies. Immune-tolerant cancer cells are insensitive to conventional death pathways such as apoptosis and necrosis, whereas mesenchymal and metastasis-prone cancer cells are particularly vulnerable to ferroptosis, which plays a vital role in mediating immune tolerance resistance by tumors and immune cells...
April 12, 2024: Critical Reviews in Oncology/hematology
https://read.qxmd.com/read/38615735/anemia-and-iron-supplementation-in-relation-to-viral-load-and-mortality-among-70-442-people-living-with-hiv-in-tanzania
#38
JOURNAL ARTICLE
Ajibola Ibraheem Abioye, Christopher R Sudfeld, Ramadhani Abdallah Noor, Nzovu Ulenga, David Sando, Wafaie W Fawzi
BACKGROUND: Anemia may be associated with poor clinical outcomes among people living with HIV (PLHIV) despite highly active antiretroviral therapy (HAART). There are concerns that iron supplementation may be unsafe to prevent and treat anemia among PLHIV. We sought to evaluate the associations of anemia and iron supplementation with mortality and viral load among PLHIV in Tanzania. METHODS: We analyzed data from a cohort of 70,442 non-pregnant adult PLHIV in Tanzania conducted between 2015 and 2019...
April 12, 2024: Journal of Nutrition
https://read.qxmd.com/read/38613949/accurate-gamma-ray-dose-measurement-up-to-10%C3%A2-mev-by-glass-dosimeter-with-a-sensitivity-control-filter-for-bnct
#39
JOURNAL ARTICLE
F Kamisaki, T Inoue, K Tomiyoshi, M Matsuki, K Aoki, S Kusaka, S Tamaki, F Sato, I Murata
Glass dosimeters are very useful and convenient detection elements in radiation dosimetry. In this study, this glass dosimeter was applied to a BNCT treatment field. Boron Neutron Capture Therapy (BNCT) is a next-generation radiation therapy that can selectively kill only cancer cells. In the BNCT treatment field, both neutrons and secondary gamma-rays are generated. In other words, it is a mixed radiation field of neutrons and gamma-rays. We thus proposed a novel method to measure only gamma-ray dose in the mixed field using two RPLGD (Radiophoto-luminescence Glass Dosimeter) and two sensitivity control filters in order to control the dose response of the filtered RPLGD to be proportional to the air kerma coefficients, even if the gamma-ray energy spectrum is unknown...
March 22, 2024: Applied Radiation and Isotopes
https://read.qxmd.com/read/38612557/iron-metabolism-and-inflammatory-mediators-in-patients-with-renal-dysfunction
#40
REVIEW
Tomomi Matsuoka, Masanori Abe, Hiroki Kobayashi
Chronic kidney disease (CKD) affects around 850 million people worldwide, posing significant challenges in healthcare due to complications like renal anemia, end-stage kidney disease, and cardiovascular diseases. This review focuses on the intricate interplay between iron metabolism, inflammation, and renal dysfunction in CKD. Renal anemia, prevalent in CKD, arises primarily from diminished erythropoietin (EPO) production and iron dysregulation, which worsens with disease progression. Functional and absolute iron deficiencies due to impaired absorption and chronic inflammation are key factors exacerbating erythropoiesis...
March 27, 2024: International Journal of Molecular Sciences
keyword
keyword
19239
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.